Clinical pharmacology of ramipril

This publication has 13 references indexed in Scilit:

• Pharmacokinetics and pharmacodynamics of ramipril in renal failure
  The American Journal of Cardiology, 1987
• A dose‐response study of HOE 498, a new non‐sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin‐ angiotensin‐aldosterone system in normal man.
  British Journal of Clinical Pharmacology, 1985
• A need for new converting enzyme inhibitors?
  BMJ, 1985
• The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
• Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.
  British Journal of Clinical Pharmacology, 1984
• "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
  BMJ, 1984
• Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects
  European Journal of Clinical Pharmacology, 1984
• Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.
  British Journal of Clinical Pharmacology, 1982
• Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
  BMJ, 1981
• Maintenance of blood pressure by the renin–angiotensin system in normal man
  Nature, 1981